Your browser doesn't support javascript.
loading
Efficacy and safety of prolonged release budesonide granules in mesalazine-refractory ulcerative colitis: A multi-centre Phase IIa study (TOPICAL-1).
Fellermann, Klaus; Schiefke, Ingolf; Rácz, István; Derova, Jelena; Jonaitis, Laimas; Wehrum, Sarah; Nacak, Tanju; Greinwald, Roland.
Afiliação
  • Fellermann K; Department of Internal Medicine I, University Hospital Schleswig Holstein, Lübeck, Germany.
  • Schiefke I; Department of Gastroenterology, Hepatology, Diabetology and Endocrinology, Klinikum St Georg gGmbH and Internal Medicine, EUGASTRO GmbH, Leipzig, Germany.
  • Rácz I; Department of Internal Medicine, Petz Aladár County Hospital, Gyor, Hungary.
  • Derova J; Department of Gastroenterology, Latvian Maritime Medical Centre, Riga, Latvia.
  • Jonaitis L; Department of Gastroenterology, Lithuanian University of Health Sciences, Kaunas, Lithuania.
  • Wehrum S; Clinical Research and Development Department, Dr Falk Pharma GmbH, Freiburg, Germany.
  • Nacak T; Clinical Research and Development Department, Dr Falk Pharma GmbH, Freiburg, Germany.
  • Greinwald R; Clinical Research and Development Department, Dr Falk Pharma GmbH, Freiburg, Germany.
United European Gastroenterol J ; 8(10): 1186-1195, 2020 12.
Article em En | MEDLINE | ID: mdl-33028169
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Mesalamina / Budesonida / Anti-Inflamatórios Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Mesalamina / Budesonida / Anti-Inflamatórios Tipo de estudo: Clinical_trials / Diagnostic_studies / Prognostic_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article